Skip to content

Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological and Clinical Approach

Andrés David Turizo Smith, Natalia Jaramillo, Diana Milena Berrío Cuartas

Medical & Clinical Case Reports Journal May 19, 2025 DOI: 10.51219/mccrj/andres-david-turizo-smith/233 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Psilocybin End-of-life distress
Keywords Palliative care Intensive care medicine Hallucinogen Nursing Pharmacology
Key findings Psilocybin may improve quality of life in palliative care by reducing psychological distress and enhancing emotional well-being.

Abstract

Psilocybin, a psychedelic compound in certain mushrooms, has been used for centuries in spiritual ceremonies and neuropsychiatric therapy.Despite its stigmatization as a Schedule I substance in 1970, research into psilocybin has resurged since the early 2000s, particularly in psychiatry and palliative care.This review examines psilocybins potential to improve the quality of life in palliative care by reducing psychological distress and enhancing emotional well-being.The discussion includes its historical context, pharmacokinetics, pharmacodynamics, legal status and future perspectives in palliative care.

Comparable studies

Other narrative reviews on psilocybin for end-of-life distress, most cited first.

Explore topics

By condition and practice